Noble metal nanoparticles have become central components of biosensor design, yet their contribution is often described mainly in terms of signal enhancement or diagnostic performance. This review takes a complementary perspective by focusing on how gold, silver, and platinum nanoparticles become functional biosensing interfaces through controlled synthesis, interfacial incorporation, surface functionalization, characterization, and analytical validation. We first examine how colloidal synthesis, direct substrate growth, electrodeposition, thin-film-derived nanostructuring, organized film assembly, and nanocomposite formation produce interfaces with distinct optical, electrical, catalytic, and surface-chemical properties. We then discuss how linker chemistry, receptor immobilization, blocking, and antifouling strategies determine whether a nanoparticle-modified surface becomes a selective biosensor. Characterization is treated as a question-driven framework for verifying nanomaterial formation, interfacial assembly, biorecognition-layer immobilization, charge-transfer or optical response, and analytical reliability. Representative electrochemical, conductometric, colorimetric, and plasmonic platforms are analyzed to show that noble metal nanoparticles do not act as universal enhancers, but rather as catalytic domains, conductive modifiers, immobilization supports, signal tags, or plasmonic transducers depending on the sensing architecture. Finally, we highlight reproducibility, matrix effects, fouling, scalability, and validation in real samples as key barriers to translation. By reframing noble metal nanoparticle biosensors as engineered interfaces, this review emphasizes that analytical performance depends on aligning material properties, interface architecture, and sensing mechanism.
No takes yet. Share an insight, caveat, or question.
Lessa et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: